approved EB-1A

Research Laboratory Specialist Intermediate

Cell Biology · China · 2023-02-22

Processing Time
40 days
Decision Date
2023-02-22
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner authored 11 peer-reviewed articles in international journals, demonstrating a consistent record of publication.

Judging (Met)

The petitioner completed 67 peer reviews for international journals and serves on the editorial board of the American Journal of Science & Research.

Original Contributions (Met)

His research in lysosome biogenesis and protein ubiquitination has been cited 224 times and is utilized by experts globally to develop therapies for genetic disorders.

Why This Petition Was Approved

The case was approved based on the petitioner's 11 peer-reviewed publications which garnered 224 citations across 21 countries. He demonstrated original contributions through 67 peer reviews for prestigious journals and an editorial board position at the American Journal of Science & Research. His research was further validated by funding from major national and international organizations including the NIH and the National Natural Science Foundation of China.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Professional Memberships
Judging Experience
Original Contributions
Evidence Submitted
  • 11 peer-reviewed articles in international journals
  • 224 citations from researchers in at least 21 countries
  • 67 peer reviews conducted for prestigious international journals
  • Editorial board membership for the American Journal of Science & Research
  • Research funding from the National Institutes of Health (NIH)
  • Research funding from the National Natural Science Foundation of China
  • Research funding from the National Key Research and Development Program of China

Similar Cases

Others

Biotechnology · India

WeGreened EB-1A approved
Massachusetts 6 days 2022-03-21
The approval was based on the petitioner's 62 peer-reviewed articles and an immense citation count of 2,342, placing her in the top 1% of highly cited authors in Biology and Medicine. Additionally, she demonstrated her expertise through 21 peer-review assignments and received funding from the National Institutes of Health (NIH). These metrics satisfied the EB-1A criteria for scholarly articles, judging, and original contributions of major significance.

Scientist

Biotechnology · India

WeGreened EB-1A approved
Illinois 37 days 2025-06-12
The petition was approved based on meeting at least three EB-1A criteria: scholarly articles, original contributions of major significance, and judging the work of others. Metrics included 13 peer-reviewed journal articles, 388 citations, and 30 instances of peer review for prestigious journals. The case was further strengthened by evidence of substantial research funding from the NIH, NSF, and U.S. Department of Energy.

Scientist

Biotechnology · India

WeGreened EB-1A approved
Tennessee 16 days 2025-04-09
The petition was approved based on the petitioner meeting at least three EB-1A criteria: original scientific contributions of major significance, authorship of scholarly articles in professional journals, and participation as a judge of the work of others. Specific metrics included over 1,600 citations, 25 peer-reviewed publications (including Cell and Nature Communications), and 70+ peer reviews.

Assistant Professor

Research and Development · India

WeGreened EB-1A approved
Michigan 18 days 2025-06-14
The petition was approved based on 14 peer-reviewed journal articles, 1 preprint, and 1 book chapter published in high-ranking journals. The petitioner demonstrated 219 citations and over 40 instances of peer review service for top scientific journals and funding agencies. Additionally, ongoing research support from prominent international funding bodies evidenced sustained recognition in the field.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 40 days
Criteria Met 3 / 3
Evidence Types 7

EB-1A Case Data

Scraped Case Data

Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist